Nurses may face “explosive growth” ahead in the use of mobile communications solutions – primarily because they’ve been ignored for so long. Indeed, 42 percent of hospitals still rely on…
read moreIn its continuing effort to make clinical trials more patient-centric and to improve the time, cost, and efficiency of developing new treatments, Eli Lilly and Company announced the winners of…
read moreWhile telemedicine can serve as a viable and convenient alternative to face-to-face primary and urgent care, particularly for rural patients, it’s not meant to totally replace such care, according to…
read moreIn contrast to other types of care providers, which have disproportionately adopted electronic health records (EHRs) in areas serving white, middle class urban and suburban populations, federally-funded community health centers…
read moreDrugDev announced this morning that it has acquired TrialNetworks. Financial terms were not disclosed, but the transaction was supported by investment from Invesco Perpetual. TrialNetworks hosts what it calls the…
read moreInvesting in interoperability is well worth it so a health system can be demarcated by its data, and not its individual buildings, according to John Bosco, CIO of Great Neck,…
read moreThe ICD-10 delay that went into effect earlier this month won’t be a total “killer” for implementation of the more advanced coding set, according to a Centers for Medicare &…
read moreOther industries have been far more successful than healthcare in mashing together big datasets to learn more about their customers. The prospect raises myriad possibilities, according to a Viewpoint article…
read moreThe definition of population health management (PHM) differs depending on whom you talk to. But the lines are blurring between PHM and financial management, according to a blog post at…
read moreWhen Jeri Burtchell entered a 2007 trial testing a first-ever MS pill, she feared the unknown, didn’t understand the medical jargon, and couldn’t tell if the informed consent was written…
read more